Mar 14, 2023 / 02:00PM GMT
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good morning. Welcome to Oppenheimer's 33rd Annual Healthcare Conference. I'm Mike Wiederhorn, health care services analyst. It's my pleasure today to have Amedisys team here. We have Chairman and CEO, Paul Kusserow; CFO and COO, Scott Ginn; Chief Strategy Officer, Nick Muscato, and incoming CEO, Richard Ashford. Well, thank you for joining us, guys. Obviously, a lot going on your end. Timing is impeccable.
Paul Berthold Kusserow - Amedisys, Inc. - Chairman & CEO
What we did is just for you Mike. We wanted to make sure that we can give you a little drama to lead in this morning.
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
But we definitely appreciate it, yes. We will sell some tickets. Well, this is fireside. So let me start, obviously, welcoming Richard here to the platform. And obviously, it started with the -- why don't you go through your background, give some
Amedisys Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot